Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tango Therapeutics, Inc. (TNGX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tango Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1819133.
Total stock buying since 2020: $18,336,244.
Total stock sales since 2020: $69,464,421.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 1,448,830 | $9,971,771 | 0 | $0 |
| 2024 | 20,000 | $74,000 | 10,231,641 | $57,193,129 | 0 | $0 |
| 2023 | 1,725,000 | $11,168,750 | 232,507 | $2,299,491 | 0 | $0 |
| 2022 | 419,000 | $1,758,494 | 0 | $0 | 0 | $0 |
| 2020 | 533,500 | $5,335,000 | 5,000 | $30 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 1,402,194 | $9,828,557 | 0 | $0 |
| 2025-02 | 0 | $0 | 46,636 | $143,214 | 0 | $0 |
| 2024-11 | 20,000 | $74,000 | 5,780,000 | $18,309,063 | 0 | $0 |
| 2024-10 | 0 | $0 | 1,508,000 | $10,449,960 | 0 | $0 |
| 2024-09 | 0 | $0 | 142,400 | $1,576,939 | 0 | $0 |
| 2024-08 | 0 | $0 | 350,000 | $3,516,140 | 0 | $0 |
| 2024-07 | 0 | $0 | 1,880,731 | $18,237,425 | 0 | $0 |
| 2024-06 | 0 | $0 | 174,000 | $1,270,450 | 0 | $0 |
| 2024-05 | 0 | $0 | 210,000 | $1,580,850 | 0 | $0 |
| 2024-02 | 0 | $0 | 186,510 | $2,252,302 | 0 | $0 |
| 2023-11 | 0 | $0 | 7,507 | $62,991 | 0 | $0 |
| 2023-10 | 1,250,000 | $8,722,500 | 225,000 | $2,236,500 | 0 | $0 |
| 2023-08 | 475,000 | $2,446,250 | 0 | $0 | 0 | $0 |
| 2022-10 | 419,000 | $1,758,494 | 0 | $0 | 0 | $0 |
| 2020-11 | 0 | $0 | 5,000 | $30 | 0 | $0 |
| 2020-09 | 533,500 | $5,335,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-22 | Trv Gp Iv, Llc | Sale | 302,194 | 7.00 | 2,115,358 |
| 2025-08-19 | Trv Gp Iv, Llc | Sale | 1,100,000 | 7.01 | 7,713,199 |
| 2025-02-05 | Barry Douglas (General Counsel) | Sale | 2,556 | 3.16 | 8,079 |
| 2025-02-05 | Crystal Adam (See Remarks) | Sale | 6,851 | 3.16 | 21,656 |
| 2025-02-05 | Weber Barbara (Chief Executive Officer) | Sale | 9,013 | 3.16 | 28,490 |
| 2025-02-05 | Beckman Daniella (Chief Financial Officer) | Sale | 3,948 | 3.16 | 12,479 |
| 2025-02-04 | Barry Douglas (General Counsel) | Sale | 2,774 | 2.99 | 8,288 |
| 2025-02-04 | Crystal Adam (See Remarks) | Sale | 7,432 | 2.99 | 22,206 |
| 2025-02-04 | Weber Barbara (Chief Executive Officer) | Sale | 9,778 | 2.99 | 29,216 |
| 2025-02-04 | Beckman Daniella (Chief Financial Officer) | Sale | 4,284 | 2.99 | 12,800 |
| 2024-11-18 | Rothenberg Mace | Buy | 10,000 | 3.78 | 37,800 |
| 2024-11-14 | Rothenberg Mace | Buy | 10,000 | 3.62 | 36,200 |
| 2024-11-07 | Ecor1 Capital, Llc | Sale | 1,205,442 | 3.10 | 3,741,691 |
| 2024-11-06 | Ecor1 Capital, Llc | Sale | 1,494,558 | 3.28 | 4,896,172 |
| 2024-11-06 | Davis Aaron I. | Sale | 3,080,000 | 3.14 | 9,671,200 |
| 2024-10-25 | Davis Aaron I. | Sale | 633,000 | 6.87 | 4,348,710 |
| 2024-10-22 | Davis Aaron I. | Sale | 250,000 | 6.78 | 1,695,000 |
| 2024-10-21 | Davis Aaron I. | Sale | 625,000 | 7.05 | 4,406,250 |
| 2024-09-13 | Trv Gp Iv, Llc | Sale | 67,400 | 10.53 | 709,789 |
| 2024-09-05 | Trv Gp Iv, Llc | Sale | 75,000 | 11.56 | 867,150 |
| 2024-08-27 | Trv Gp Iv, Llc | Sale | 25,000 | 11.55 | 288,675 |
| 2024-08-19 | Trv Gp Iv, Llc | Sale | 150,000 | 10.09 | 1,513,950 |
| 2024-08-16 | Trv Gp Iv, Llc | Sale | 135,000 | 9.79 | 1,321,515 |
| 2024-08-01 | Trv Gp Iv, Llc | Sale | 40,000 | 9.80 | 392,000 |
| 2024-07-31 | Trv Gp Iv, Llc | Sale | 100,000 | 9.93 | 993,399 |
| 2024-07-30 | Trv Gp Iv, Llc | Sale | 95,000 | 9.80 | 931,095 |
| 2024-07-26 | Trv Gp Iv, Llc | Sale | 50,000 | 9.84 | 491,950 |
| 2024-07-25 | Trv Gp Iv, Llc | Sale | 100,599 | 9.87 | 992,811 |
| 2024-07-24 | Trv Gp Iv, Llc | Sale | 200,000 | 9.82 | 1,963,200 |
| 2024-07-23 | Trv Gp Iv, Llc | Sale | 125,000 | 9.79 | 1,223,375 |
| 2024-07-22 | Trv Gp Iv, Llc | Sale | 262,740 | 9.78 | 2,570,122 |
| 2024-07-18 | Trv Gp Iv, Llc | Sale | 191,490 | 9.81 | 1,878,516 |
| 2024-07-17 | Trv Gp Iv, Llc | Sale | 550,171 | 9.79 | 5,386,174 |
| 2024-07-02 | Davis Aaron I. | Sale | 95,000 | 8.68 | 824,600 |
| 2024-07-01 | Davis Aaron I. | Sale | 110,731 | 8.87 | 982,183 |
| 2024-06-28 | Davis Aaron I. | Sale | 29,000 | 8.57 | 248,530 |
| 2024-06-07 | Davis Aaron I. | Sale | 77,000 | 6.88 | 529,760 |
| 2024-06-06 | Davis Aaron I. | Sale | 63,000 | 7.24 | 456,120 |
| 2024-06-05 | Calhoun Lesley Ann | Sale | 5,000 | 7.21 | 36,040 |
| 2024-05-03 | Davis Aaron I. | Sale | 60,000 | 7.61 | 456,600 |
| 2024-05-02 | Davis Aaron I. | Sale | 75,000 | 7.56 | 567,000 |
| 2024-05-01 | Davis Aaron I. | Sale | 75,000 | 7.43 | 557,250 |
| 2024-02-20 | Trv Gp Iv, Llc | Sale | 162,500 | 12.00 | 1,950,000 |
| 2024-02-07 | Barry Douglas (General Counsel) | Sale | 1,354 | 12.62 | 17,087 |
| 2024-02-07 | Crystal Adam (See Remarks) | Sale | 4,083 | 12.62 | 51,527 |
| 2024-02-07 | Weber Barbara (Chief Executive Officer) | Sale | 4,457 | 12.62 | 56,247 |
| 2024-02-07 | Beckman Daniella (Chief Financial Officer) | Sale | 1,817 | 12.62 | 22,930 |
| 2024-02-06 | Barry Douglas (General Counsel) | Sale | 1,422 | 12.56 | 17,864 |
| 2024-02-06 | Crystal Adam (See Remarks) | Sale | 4,288 | 12.56 | 53,870 |
| 2024-02-06 | Weber Barbara (Chief Executive Officer) | Sale | 4,681 | 12.56 | 58,807 |
| 2024-02-06 | Beckman Daniella (Chief Financial Officer) | Sale | 1,908 | 12.56 | 23,970 |
| 2023-11-01 | Crystal Adam (See Remarks) | Sale | 7,507 | 8.39 | 62,991 |
| 2023-10-16 | Boxer Asset Management Inc. | Buy | 500,000 | 6.84 | 3,420,000 |
| 2023-10-13 | Boxer Asset Management Inc. | Buy | 750,000 | 7.07 | 5,302,500 |
| 2023-10-09 | Davis Aaron I. | Sale | 225,000 | 9.94 | 2,236,500 |
| 2023-08-11 | Davis Aaron I. | Buy | 475,000 | 5.15 | 2,446,250 |
| 2022-10-13 | Davis Aaron I. (Director) | Buy | 70,000 | 4.65 | 325,220 |
| 2022-10-12 | Davis Aaron I. (Director) | Buy | 50,000 | 4.43 | 221,650 |
| 2022-10-11 | Davis Aaron I. (Director) | Buy | 117,000 | 4.25 | 497,717 |
| 2022-10-06 | Lewis Joseph (10% Owner) | Buy | 70,394 | 4.06 | 286,081 |
| 2022-10-05 | Lewis Joseph (10% Owner) | Buy | 86,000 | 3.88 | 333,852 |
| 2022-10-04 | Lewis Joseph (10% Owner) | Buy | 25,606 | 3.67 | 93,974 |
| 2020-11-20 | Bctg Holdings, Llc | Sale | 5,000 | .01 | 30 |
| 2020-09-08 | Bctg Holdings, Llc | Buy | 533,500 | 10.00 | 5,335,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of TNGX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tango Therapeutics, Inc. (symbol TNGX, CIK number 1819133) see the Securities and Exchange Commission (SEC) website.